Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621943 · ClinicalTrials.gov registry record · NA
Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)
A NA study of Neurodevelopmental Abnormality, sponsored by Sharp HealthCare.
- Completed
- Registry status
- NA
- Development phase
- 1,207
- Enrollment target
- 10
- Study locations
NCT03621943 is a NA study of Neurodevelopmental Abnormality that has completed, run by Sharp HealthCare. The registered enrollment target is 1,207 participants. The trial reports 10 study locations across 7 states.
The verdict
NCT03621943, a NA study of Neurodevelopmental Abnormality, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,207 participants
- Enrollment target
- 10
- Study locations
Study Summary
A sub-study to evaluate longer-term developmental outcomes in non-vigorous term and near-term newborns who receive umbilical cord milking in comparison to those who undergo early cord clamping at delivery.
Conditions Studied
Interventions
- PROCEDURE Umbilical Cord Milking
- PROCEDURE Early Cord Clamping
Study Locations (10)
California
- University of California, Davis - Davis
- Loma Linda Medical Center - Loma Linda
- Sharp Grossmont Hospital - San Diego
- Sharp Mary Birch Hospital for Women and Newborns - San Diego
District of Columbia
- George Washington University - Washington D.C.
Oregon
- Providence St. Vincent Medical Center - Portland
Utah
- University of Utah/IMH - Salt Lake City
Alberta
- University of Alberta - Edmonton
New Brunswick
- Dalhousie University - Dalhousie
Other
- Poznan University of Medical Science - Poznan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,207 participants |
| Start Date | 2019-01-07 |
| Est. Completion | 2023-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621943
The ClinicalTrials.gov registry entry for NCT03621943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurodevelopmental Abnormality appearing as the primary indexed condition, and to 2 interventions - of which Umbilical Cord Milking is the first listed.
NCT03621943 reports 10 study locations spanning 7 distinct geographic areas - top geographies include California, District of Columbia, Oregon.
Frequently Asked Questions
What is clinical trial NCT03621943 about?
NCT03621943 is a clinical study titled "Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)". A sub-study to evaluate longer-term developmental outcomes in non-vigorous term and near-term newborns who receive umbilical cord milking in comparison to those who undergo early cord clamping at delivery.
What is the current status of trial NCT03621943?
This trial is currently completed. It is a NA study. The enrollment target is 1,207 participants. The study started on 2019-01-07. Estimated completion is 2023-09-26.
What conditions does trial NCT03621943 study?
This clinical trial studies the following conditions: Neurodevelopmental Abnormality.
What interventions are being tested in trial NCT03621943?
The interventions under investigation include: Umbilical Cord Milking (PROCEDURE), Early Cord Clamping (PROCEDURE).
Who is sponsoring clinical trial NCT03621943?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03621943 being conducted?
This trial has 10 study locations across California, District of Columbia, Oregon, Utah, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurodevelopmental Abnormality
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.